Solara Active Pharma Sciences Limited (NSE:SOLARAPP1)
India · Delayed Price · Currency is INR 449.85
+3.00 (0.67%)
At close: Aug 1, 2025, 3:30 PM IST
Revance Therapeutics Market Cap
NSE:SOLARAPP1 has a market cap or net worth of 29.10 billion as of August 1, 2025. Its market cap has increased by 7.26% in one year.
Market Cap
29.10B
Enterprise Value
37.05B
Revenue
12.39B
Ranking
n/a
PE Ratio
118.69
Stock Price
$449.85
Market Cap Chart
Since June 27, 2018, NSE:SOLARAPP1's market cap has increased from 6.21B to 29.10B, an increase of 368.53%. That is a compound annual growth rate of 24.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 29.10B | -10.78% |
| Dec 31, 2024 | 32.62B | 150.91% |
| Dec 29, 2023 | 13.00B | -16.05% |
| Dec 30, 2022 | 15.49B | -57.73% |
| Dec 31, 2021 | 36.63B | -14.39% |
| Dec 31, 2020 | 42.79B | 277.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 17.71T |
| HDFC Bank | 15.43T |
| Bharti Airtel | 11.30T |
| Tata Consultancy Services | 10.99T |
| ICICI Bank | 10.50T |
| State Bank of India | 7,353.27B |
| Infosys | 6,091.75B |
| Hindustan Unilever | 5,923.79B |